Earnings
CLVS
4.660
+4.96%
0.220
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2019-12-31
143.01M
143.01M
34.69M
108.32M
182.77M
283.15M
--
--
9.71M
528.02M
--
-385.02M
-19.95M
--
6.34M
-19.95M
-398.63M
1.80M
-400.42M
--
-400.42M
-400.42M
--
--
-7.43
FY 2018-12-31
95.39M
95.39M
22.07M
73.31M
175.78M
231.35M
--
--
--
457.18M
--
-361.79M
-13.53M
--
7.92M
-13.53M
-367.40M
608.00K
-368.01M
--
-368.01M
-368.01M
--
--
-7.07
FY 2017-12-31
55.51M
55.51M
11.74M
43.77M
138.91M
142.50M
--
--
--
398.62M
--
-343.11M
-10.51M
--
3.64M
-10.51M
-349.98M
-165.78M
-184.20M
--
-184.20M
-184.20M
-162.20M
--
-3.92
FY 2016-12-31
78.00K
78.00K
70.00K
8000.00
40.73M
251.13M
--
--
--
372.81M
--
-372.73M
-9.07M
--
633.00K
-9.07M
-381.17M
-32.03M
-349.14M
--
-349.14M
-349.14M
--
--
-9.07
FY 2015-12-31
0.00
0.00
--
--
30.52M
269.25M
--
--
--
376.72M
--
-376.72M
-5.63M
--
416.00K
-5.63M
-381.94M
-29.08M
-352.86M
--
-352.86M
-352.86M
--
--
-9.79

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out CLVS latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Clovis Oncology recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.